lumopeak ghk-cu peptide serum GHK-Cu Super Serum w/ SNAP-8
Description
Using co-immunoprecipitation (CO-IP), the study confirmed that FOXO4-DRI prevents FOXO4 binding to p53, facilitating phosphorylated p53 nuclear exclusion, which triggers BAX upregulation and cleaved caspase-3 activation driving selective apoptosis of senescent endothelial cells

Methylcobalamin - this is a naturally occurring co-enzyme and a highly bioavailable form of B12 and is found in natural food sources

The CAS registry number for AOD9604 is 221231-10-3

This commitment to pharmaceutical-grade quality is what separates physician-supervised peptide therapy from the gray market products that have proliferated in recent years
